ATXI (ATXI) Stock Price & Analysis
ATXI (ATXI) rose 0.00% to USD 0.28 as of July 25, 2026 at 04:35 UTC, according to Nexqual real-time market data.
ATXI last closed at USD 0.28; the session ranged USD 0.26–0.26 on volume of 1 shares. Market capitalization is —, with a 52-week range of USD 0.15–0.97 (OID). Source: Nexqual, July 25, 2026 at 04:35 UTC.
Key Statistics (as of July 25, 2026 at 04:35 UTC)
| Price | USD 0.28 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.28 |
| Open | USD 0.28 |
| Day Range | USD 0.26 – 0.26 |
| 52-Week Range | USD 0.15 – 0.97 |
| Volume | 1 shares |
| Market Cap | — |
| Exchange | OID |
Technical Analysis (ATXI)
Nexqual's technical model rates ATXI "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:35 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.77 (neutral) |
| vs SMA50 | Below (USD 0.3) |
| MACD | -0.02 (negative) |
From ATXI's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARDS | Aridis Pharmaceuticals Inc. | USD 0 | ▲ 0% |
| KPRX | Kiora Pharmaceuticals, Inc. | USD 2.55 | ▲ 0.79% |
| ADTX | Aditxt, Inc. | USD 0 | ▲ 33.33% |
| PALI | Palisade Bio, Inc. | USD 1.95 | ▲ 2.63% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.26 | ▼ 7.96% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:35 UTC. This page is informational and not investment advice.